Table 2.
Case 1 baseline and after treatment outcome measures.
| Baseline | Week 3 | Week 7 | COR | ||||
|---|---|---|---|---|---|---|---|
| OD | OS | OD | OS | OD | OS | ||
| Visual Acuity (VA) | 20/20 | 20/25 | 20/20 | 20/25 | 20/20 | 20/25 | |
| Retinal sensitivity (dB) | 14.3 | 14.4 | 14 | 11.8 | 14.7 | 12.4 | ±1.51 |
| Bivariate Contour Ellipse Area 63% (BCEA, 2) | 0.4 | 0.6 | 0.5 | 0.5 | 0.3 | 0.5 | ±0.61 |
| Humphrey Full Field | 48/81 | 37/81 | 47/81 (−1) | 43/81 (+6) | 50/81 (+2) | 46/81 (+9) | |
| (points seen) | (59.3%) | (45.7%) | (58.0%) | (53.1%) | (61.7%) | (56.8%) | |
| Esterman binocular field | 66/120 | 69/120 (+3) | 73/120 (+7) | ±3 adjacent points | |||
| (points seen) | (55%) | (57.5%) | (60.8%) | ||||
| Reading speed (wpm) | 109 | 160 | 120 | ±8.6 | |||
| Quality of life (orientation and mobility) | 3.48 | 3.01 | 3.48 | ±0.44 | |||
OD, oculus dexter; OS, oculus sinister; dB, decibels; wpm, words per minute; COR, coefficient of repeatability.